A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...

Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

But there are specific kinds that are best: “Cough medicines that contain guaifenesin and dextromethorphan should be okay for a short time,” says Meleen Chuang, MD, the chief of obstetrics and ...

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

“I am delighted to see this nasal vaccination technology, created by scientists right here at WashU Medicine, advance toward clinical trials,” said Doug E. Frantz, PhD, the Vice Chancellor for ...

An ear, nose and throat doctor explains why tipping your head back with a nosebleed could make things worse and what you ...

A new clinic in Stratford is offering ketamine treatment to help people with mental health conditions.Ketamine has been used ...